8:00 Welcome and Introduction.
Dave Eaton and Linda Greer
8:10 Role of non-tumor data in assessment of carcinogenicity.
Jim Bus
8:50 Key issues (common critical gaps) in cancer determinations.
Jack Moore
9:45 Break
10:00 What types of toxicogenomics experiments have been attempted to address critical gaps in risk assessment?
Cheryl Walker and Ken Ramos
10:45 Case Study Discussion: Identify specific situations in risk assessment where toxicogenomics could be very useful and where it would be less useful.
Overview of method for case studies discussion.
Linda Greer
Case Study Discussion I:
• Presentation of 1,3-Butadiene Risk Assessment. Ken Ramos
• Discussion of 1,3-Butadiene Risk Assessment questions that might be addressed with toxicogenomics techniques. Ken Ramos
1:30 Case Study Discussion II:
• Presentation of Arsenic Risk Assessment. David Eaton
• Discussion of Arsenic Risk Assessment questions that might be addressed with toxicogenomics techniques. Cheryl Walker
3:15 Break
3:35 Discussion and summary of issues presented in each of the two chemicals, with an aim of generalizing to list of opportunities for the field of toxicogenomics.
Linda Greer
5:15 Adjourn

From: Appendix A, Workshop Agenda

Cover of Toxicogenomic Technologies and Risk Assessment of Environmental Carcinogens
Toxicogenomic Technologies and Risk Assessment of Environmental Carcinogens: A Workshop Summary.
National Research Council (US) Committee on How Toxicogenomics Could Inform Critical Issues in Carcinogenic Risk Assessment of Environmental Chemicals.
Washington (DC): National Academies Press (US); 2005.
Copyright © 2005, National Academy of Sciences.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.